Corporate News     15-Sep-20
Board of Gufic BioSciences accepts cessation of director
At meeting held on 14 September 2020
The Board of Gufic BioSciences at its meeting held on 14 September 2020 has approved the cessation of Hemal M. Desai as a Whole Time Director of the Company effective 30 September 2020 on completion of her tenure.
Previous News
  Gufic BioSciences standalone net profit rises 279.77% in the September 2020 quarter
 ( Results - Announcements 13-Nov-20   08:31 )
  Board of Gufic BioSciences recommends final dividend
 ( Corporate News - 30-May-23   15:18 )
  Gufic BioSciences to convene board meeting
 ( Corporate News - 08-Aug-23   16:08 )
  Gufic BioSciences standalone net profit rises 11.33% in the September 2018 quarter
 ( Results - Announcements 15-Nov-18   13:47 )
  Gufic BioSciences standalone net profit declines 2.04% in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   07:35 )
  Gufic Biosciences launches indigenously produced Dual Chamber Bags
 ( Corporate News - 06-Jun-22   19:18 )
  Board of Gufic BioSciences decides to withdraw scheme of amalgamation
 ( Corporate News - 21-Jun-18   11:17 )
  Gufic BioSciences net profit rises 12.90% in the June 2007 quarter
 ( Results - Announcements 01-Aug-07   19:25 )
  Gufic Biosciences to consider dividend
 ( Corporate News - 06-Jun-12   15:14 )
  TCI Finance Ltd leads losers in 'B' group
 ( Hot Pursuit - 17-Aug-21   14:45 )
  Gufic BioSciences to declare Quarterly Result
 ( Corporate News - 08-Feb-24   19:14 )
Other Stories
  Mahindra Lifespace Developers acquires 2.37 land for development in South Bengaluru
  04-Jul-24   18:27
  Mahindra Lifespace Developers to undertake redevelopment project in Borivali, Mumbai
  04-Jul-24   18:25
  Ahluwalia Contracts wins order of Rs 572 cr
  04-Jul-24   18:13
  Dilip Buildcon divest 51% stake in project SPV (Pathrapali Kathgora Highways)
  04-Jul-24   18:06
  NBCC (India) wins work order from National Institute of Technology
  04-Jul-24   16:15
  CAMS appoints director
  04-Jul-24   16:13
  Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
  04-Jul-24   16:11
  Board of Lloyds Metals & Energy approves allotment of convertible warrants aggregating Rs 2960 cr
  04-Jul-24   16:07
  Oil India allots 54.22 crore equity shares under bonus issue
  04-Jul-24   15:41
  Ishaan Infrastructure & Shelters cancels board meeting
  04-Jul-24   15:26
Back Top